Phosphate binder is an effective intervention for mitigating hyperphosphataemia, which attenuates the direct stimulatory effect on PTH secretion, reduces the formation of calcium–phosphate complexes responsible for hypocalcaemia-induced PTH secretion, and lowers FGF-23 levels, indirectly influencing PTH secretion. The gene discussed is FGF23; the disease is Hypocalcemia.